Determinants of Significant Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation

JACC: Cardiovascular Interventions - Tập 2 Số 9 - Trang 821-827 - 2009
Delphine Détaint1, Laurent Lepage1, Dominique Himbert1, Éric Brochet1, David Messika‐Zeitoun1, Bernard Iung1, Alec Vahanian1
1Cardiology Department, Hopital Bichat, Paris, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Cribier, 2002, Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description, Circulation, 106, 3006, 10.1161/01.CIR.0000047200.36165.B8

Cribier, 2004, Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis, J Am Coll Cardiol, 43, 698, 10.1016/j.jacc.2003.11.026

Cribier, 2006, Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience, J Am Coll Cardiol, 47, 1214, 10.1016/j.jacc.2006.01.049

Webb, 2006, Percutaneous aortic valve implantation retrograde from the femoral artery, Circulation, 113, 842, 10.1161/CIRCULATIONAHA.105.582882

Webb, 2007, Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis, Circulation, 116, 755, 10.1161/CIRCULATIONAHA.107.698258

Grube, 2006, Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study, Circulation, 114, 1616, 10.1161/CIRCULATIONAHA.106.639450

Grube, 2007, Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome, J Am Coll Cardiol, 50, 69, 10.1016/j.jacc.2007.04.047

Descoutures, 2008, Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly, Eur Heart J, 29, 1410, 10.1093/eurheartj/ehn081

Piazza, 2008, Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval, EuroIntervention, 4, 242, 10.4244/EIJV4I2A43

Vahanian, 2008, Eur Heart J, 29, 1463, 10.1093/eurheartj/ehn183

Lichtenstein, 2006, Transapical transcatheter aortic valve implantation in humans: initial clinical experience, Circulation, 114, 591, 10.1161/CIRCULATIONAHA.106.632927

Ye, 2006, Transapical aortic valve implantation in humans, J Thorac Cardiovasc Surg, 131, 1194, 10.1016/j.jtcvs.2006.01.026

Walther, 2007, Minimally invasive transapical beating heart aortic valve implantation—proof of concept, Eur J Cardiothorac Surg, 31, 9, 10.1016/j.ejcts.2006.10.034

Walther, 2007, Transapical minimally invasive aortic valve implantation: multicenter experience, Circulation, 116, I240, 10.1161/CIRCULATIONAHA.106.677237

Oh, 1988, Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients, J Am Coll Cardiol, 11, 1227, 10.1016/0735-1097(88)90286-0

Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8

Zoghbi, 2003, Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography, J Am Soc Echocardiogr, 16, 777, 10.1016/S0894-7317(03)00335-3

Bonow, 2006, J Am Coll Cardiol, 48, e1, 10.1016/j.jacc.2006.05.021

Vahanian, 2007, Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, Eur Heart J, 28, 230

Moss, 2008, Role of echocardiography in percutaneous aortic valve implantation, J Am Coll Cardiol Img, 1, 15, 10.1016/j.jcmg.2007.09.004

Ionescu, 2003, Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography, Heart, 89, 1316, 10.1136/heart.89.11.1316

Rallidis, 1999, Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up, Am Heart J, 138, 351, 10.1016/S0002-8703(99)70124-9

O'Rourke, 2001, Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography, J Am Coll Cardiol, 38, 163, 10.1016/S0735-1097(01)01361-4

Webb, 2007, Transcatheter percutaneous and transapical aortic valve replacement, Semin Thorac Cardiovasc Surg, 19, 304, 10.1053/j.semtcvs.2007.11.001

Ye, 2007, Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients, Eur J Cardiothorac Surg, 31, 16, 10.1016/j.ejcts.2006.10.023

Zegdi, 2008, Is it reasonable to treat all calcified stenotic aortic valves with a valved stent?, J Am Coll Cardiol, 51, 579, 10.1016/j.jacc.2007.10.023

Pibarot, 2006, Prosthesis-patient mismatch: definition, clinical impact, and prevention, Heart, 92, 1022, 10.1136/hrt.2005.067363

Pibarot, 2000, Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention, J Am Coll Cardiol, 36, 1131, 10.1016/S0735-1097(00)00859-7

Rahimtoola, 1978, The problem of valve prosthesis-patient mismatch, Circulation, 58, 20, 10.1161/01.CIR.58.1.20

Barbaliaros, 2008, Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size?, J Am Coll Cardiol Intv, 1, 580, 10.1016/j.jcin.2008.06.010

Kapur, 1989, Doppler color flow mapping in the evaluation of prosthetic mitral and aortic valve function, J Am Coll Cardiol, 13, 1561, 10.1016/0735-1097(89)90350-1